sanofi-aventis wins unanimous jury verdict in Arava antitrust litigation
Clients sanofi-aventis S.A.
Jones Day defended sanofi-aventis in an antitrust jury trial involving the claims of a class of drug wholesalers that sanofi had unlawfully blocked generic competition for its rheumatoid arthritis drug Arava. The jury unanimously vindicated sanofi-aventis’s filing of a Citizen Petition before the Food and Drug Administration in relation to Abbreviated New Drug Applications for the rheumatoid arthritis medication leflunomide.
Louisiana Wholesale Drug Co. Inc. v. sanofi-aventis, et al., Case No. 07-7343 (S.D.N.Y.)